Product Description
A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Pertechnetate)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Intravenous
FDA Designation: *
Approval Status: Approved
Approved Countries: Australia | Austria | Belgium | Bosnia | Brazil | Bulgaria | Canada | China | Colombia | Croatia | Czech | Denmark | Dominican Republic | Estonia | Finland | France | Greece | Hong Kong | Hungary | Ireland | Italy | Korea | Latvia | Lithuania | Luxembourg | Malaysia | Malta | Netherlands | Norway | Poland | Portugal | Romania | Russia | Serbia | Singapore | Slovakia | Slovenia | Spain | Sweden | Switzerland | Taiwan | Turkey | Ukraine | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: IIS LA FE
Company Location: Europe
Company Founding Year: 2013
Additional Commercial Interests: None
Clinical Description
Countries in Clinic: Spain
Active Clinical Trial Count: 1
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Ovarian Cancer
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
2024-520189-67-00 |
SENTOV II | P3 |
Not yet recruiting |
Ovarian Cancer |
2028-06-02 |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
01/13/2026 |
News Article |
Americhem to Spotlight New Materials Addressing PFAS, Traceability, and Performance Demands in Medical Devices at Pharmapack and MD&M West 2026 |
|
01/02/2026 |
News Article |
Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies |
|
01/02/2026 |
News Article |
SHINE Completes Acquisition of Lantheus SPECT Business, Names Michael Rossi SHINE SPECT CEO |
|
05/06/2025 |
News Article |
Lantheus Announces Sale of SPECT Business to SHINE Technologies |